Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)

  Print   

Tuesday 29 November, 2016

Benchmark Hlgs PLC

Capital Markets Day

RNS Number : 3591Q
Benchmark Holdings PLC
29 November 2016
 

Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")

Capital Markets Day

Benchmark Holdings, the aquaculture biotechnology and food chain sustainability business, announces that it will be holding its first Capital Markets Day for analysts and institutional investors today in London at 1 PM.   

No new material information will be disclosed, and all presentation materials will be made available on the Company's website (www.benchmarkplc.com) shortly after the event.

-Ends-

 For further information, please contact:

 


Benchmark Holdings plc

Tel: 020 7920 3150

Malcolm Pye, CEO


Roland Bonney, COO


Rachel Aninakwah, Communications




Numis

Tel: 020 7260 1000

Michael Meade / Freddie Barnfield (NOMAD)


James Black (Corporate Broking)




Tavistock

Tel: 020 7920 3150

Matt Ridsdale / Niall Walsh



 

 

 

 Notes to Editors:

 Founded in 2000, Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

The company has proven distribution capabilities in high growth markets and through these it provides world leading:  Products - through an integrated package of high genetic merit breeding stock, next era vaccines, pharmaceuticals and biocides and  advanced nutrition diets for the early stages of production; Manufacturing - delivering cutting-edge technologies in animal health vaccines, aquaculture breeding production facilities /technology and state-of-the-art advanced nutrition product manufacturing; Services - from veterinary clinical and diagnostic to technical in field/on farm support and genetic programme management; Knowledge - through consultancy, professional training, technical online & book publishing and data management systems; Research - into major health and management challenges facing aquaculture, agriculture and animal health care informing the development of the group's medicines, vaccines and management technologies.

  

Benchmark operates internationally with offices in England, Scotland, Belgium, Ireland, Norway, Iceland, USA, Brazil, China, Russia, Portugal, Thailand and Chile.  As at 30 September 2016, Benchmark employed 891 people. 

For further information on Benchmark please visit www.benchmarkplc.com

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMMZMLRZGVZM

a d v e r t i s e m e n t